2-Iodobenzyl bromide - CAS 40400-13-3
Catalog: |
BB024483 |
Product Name: |
2-Iodobenzyl bromide |
CAS: |
40400-13-3 |
Synonyms: |
1-(bromomethyl)-2-iodobenzene |
IUPAC Name: | 1-(bromomethyl)-2-iodobenzene |
Description: | 2-Iodobenzyl bromide (CAS# 40400-13-3) is a useful research chemical. |
Molecular Weight: | 296.93 |
Molecular Formula: | C7H6BrI |
Canonical SMILES: | C1=CC=C(C(=C1)CBr)I |
InChI: | InChI=1S/C7H6BrI/c8-5-6-3-1-2-4-7(6)9/h1-4H,5H2 |
InChI Key: | GQFITODJWOIYPF-UHFFFAOYSA-N |
Boiling Point: | 125 °C / 4 mmHg |
Melting Point: | 54-60 °C |
Purity: | 95 % |
Density: | 2.106 g/cm3 |
Appearance: | White to tan solid |
Storage: | Refrigerator |
MDL: | MFCD00236046 |
LogP: | 3.18610 |
GHS Hazard Statement: | H302 (88.37%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P260, P261, P264, P270, P280, P285, P301+P312, P301+P330+P331, P303+P361+P353, P304+P340, P304+P341, P305+P351+P338, P310, P321, P330, P342+P311, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CZ-34625-U1 | Purine nucleoside phosphorylase inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphomas | 20201026 |
CN-111484503-A | Mikanolide derivative and preparation method and application thereof | 20200110 |
WO-2021083438-A1 | Inhibitors of purine nucleoside phosphorylase - synthesis and use thereof for treatment of t-cell acute lymphoblastic leukemia and lymphoma | 20191030 |
CN-110534658-A | Organic electroluminescence device and electronic device | 20190823 |
WO-2020157463-A1 | Disulphide compounds | 20190130 |
PMID | Publication Date | Title | Journal |
21673988 | 20110101 | Increasing the analytical sensitivity by oligonucleotides modified with para- and ortho-twisted intercalating nucleic acids--TINA | PloS one |
19105723 | 20090101 | Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound | Journal of combinatorial chemistry |
19105725 | 20090101 | Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction | Journal of combinatorial chemistry |
Complexity: | 85 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 295.86976 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 0 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 295.86976 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 0 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.4 |
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB044156
(-)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB025409
(1-Bromo-2,2,2-trifluoroethyl)benzene
Detail
-
Catalog: BB044157
(+)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB054190
(-)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB030086
(1-Bromoethyl)benzene
Detail
-
Catalog: BB078191
((3-Bromobenzyl)oxy)(tert-butyl)dimethylsilane
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS